Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
for Metastatic Breast Cancer
Drug: Palazestrant
Sites in Charlotte +13 more locations
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05508906·Phase 1·Recruiting·Listed Aug 2022